BENGALURU (Reuters) – Indian vaccine maker Bharat Biotech said on Monday it has resumed export of its COVID-19 shot, Covaxin, and has executed long-pending orders in November.
(Reporting by Shivani Singh in Bengaluru;Editing by Arun Koyyur)
India’s Bharat Biotech resumes exports of COVID-19 vaccine
Nov 29, 2021 | 3:20 AM
